This finding is consistent with data implicating hepatic metastases as a site of disease contributing to reduced response to cancer immunotherapy by drawing CD8+ T cells from systemic circulation and into hepatic sites where they undergo apoptosis [30]. Here, CD8A is linked to cancer.